Pfeffer, Paul E., Ali, Nasloon, Altraja, Alan, Lehtimäki, Lauri, Papadopoulos, Nikolaos G., Salvi, Sundeep, Costello, Richard W., Cushen, Breda, Heffler, Enrico, Iwanaga, Takashi, Al-Ahmad, Mona, Larenas-Linnemann, Désirée, Murray, Ruth, Gibson, Peter G., Fonseca, JA, Al-Lehebi, R, Rhee, CK, Perez-de-Llano, L, Perng Steve, D-W, Mahboub, B, Wang, E, Goh, C, Lyu, J, Ulrik, Charlotte, Newell, A, Alacqua, M, Belevskiy, AS, Bhutani, M, Bjermer, L, Bjornsdottir, U, Bourdin, A, Bulow, AV, Busby, J, Canonica, GW, Tran, Trung N., Cosio, BG, Dorscheid, DR, Muñoz-Esquerre, M, FitzGerald, JM, Gil, EG, Gibson, PG, Heaney, LG, Hew, M, Hilberg, O, Hoyte, F, Maspero, Jorge, Jackson, DJ, Koh, MS, Ko, H-KB, Lee, JH, Lehmann, S, Chaves Loureiro, C, Lúðvíksdóttir, D, Menzies-Gow, AN, Mitchell, P, Papaioannou, AI, Peters, Matthew, Popov, TA, Porsbjerg, CM, Salameh, L, Sirena, C, Taillé, C, Taube, C, Tohda, Y, Wechsler, ME, Price, DB, Christoff, George C., Sadatsafavi, Mohsen, Torres-Duque, Carlos A.. John Wiley & Sons; 2023. Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both.